Literature DB >> 16738013

Understanding comorbidity with depression and anxiety disorders.

Yemi Aina1, Jeffrey L Susman.   

Abstract

Comorbidity is the rule with anxiety and depressive disorders. Anxiety and major depressive disorder are often comorbid with each other; these disorders are commonly associated with other psychiatric disorders; and they are frequently found coexisting with long-standing chronic medical conditions such as cardiovascular disease and diabetes mellitus. The comorbidity of major depressive and anxiety disorders is associated with barriers to treatment and worse psychiatric outcomes, including treatment resistance, increased risk for suicide, greater chance for recurrence, and greater utilization of medical resources. Effective recognition and treatment of anxiety and depression may be associated with functional improvement in the medical disorders (eg, lower HbA1c level in patients with diabetes). Paying careful attention to the development of anxiety and depression may also positively impact the economic burden of these disorders. To help primary care physicians better understand the comorbidity of depression and anxiety and medical disorders, the authors describe three case scenarios.

Entities:  

Mesh:

Year:  2006        PMID: 16738013

Source DB:  PubMed          Journal:  J Am Osteopath Assoc        ISSN: 0098-6151


  39 in total

1.  Supplemental dietary choline during development exerts antidepressant-like effects in adult female rats.

Authors:  Melissa J Glenn; Raven S Adams; Lauren McClurg
Journal:  Brain Res       Date:  2012-01-17       Impact factor: 3.252

2.  The HTR3A polymorphism c. -42C>T is associated with amygdala responsiveness in patients with irritable bowel syndrome.

Authors:  Lisa A Kilpatrick; Jennifer S Labus; Kristen Coveleskie; Christian Hammer; Gudrun Rappold; Kirsten Tillisch; Joshua A Bueller; Brandall Suyenobu; Johana M Jarcho; Jim A McRoberts; Beate Niesler; Emeran A Mayer
Journal:  Gastroenterology       Date:  2011-03-21       Impact factor: 22.682

3.  Measuring religiosity/spirituality in diverse religious groups: a consideration of methods.

Authors:  Devon M Berry; Colleen P Bass; Wadida Forawi; Michelle Neuman; Nagah Abdallah
Journal:  J Relig Health       Date:  2011-12

4.  The hidden health burden of environmental degradation: disease comorbidities and dryland salinity.

Authors:  Peter C Speldewinde; Angus Cook; Peter Davies; Philip Weinstein
Journal:  Ecohealth       Date:  2011-05-21       Impact factor: 3.184

5.  Diagnoses of anxiety and depression in clinical-scenario patients: survey of Saskatchewan family physicians.

Authors:  Julie Kosteniuk; Debra Morgan; Carl D'Arcy
Journal:  Can Fam Physician       Date:  2012-03       Impact factor: 3.275

6.  The economic burden of depression in Switzerland.

Authors:  Yuki Tomonaga; Josef Haettenschwiler; Martin Hatzinger; Edith Holsboer-Trachsler; Michael Rufer; Urs Hepp; Thomas D Szucs
Journal:  Pharmacoeconomics       Date:  2013-03       Impact factor: 4.981

7.  Evaluation of a Clinical Pharmacist-Led Multidisciplinary Antidepressant Telemonitoring Service in the Primary Care Setting.

Authors:  Shubha Bhat; Miranda E Kroehl; Katy E Trinkley; Zeta Chow; Lauren J Heath; Sarah J Billups; Danielle F Loeb
Journal:  Popul Health Manag       Date:  2017-12-06       Impact factor: 2.459

Review 8.  Anxiety among adolescent survivors of pediatric cancer: A missing link in the survivorship literature.

Authors:  Glynnis McDonnell; Charles Baily; Tammy Schuler; Helen Verdeli
Journal:  Palliat Support Care       Date:  2014-04-28

9.  Augmentation therapy with alpha-lipoic acid and desvenlafaxine: a future target for treatment of depression?

Authors:  Márcia Calheiros Chaves Silva; Caren Nádia Soares de Sousa; Luis Rafael Leite Sampaio; Naiara Coelho Ximenes; Paulo Victor Pontes Araújo; Jéssica Calheiros da Silva; Suzyana Lima de Oliveira; Francisca Cléa Florenço Sousa; Danielle Silveira Macêdo; Silvânia Maria Mendes Vasconcelos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-04-16       Impact factor: 3.000

10.  Relationship between Psychological Factors and Quality of Life in Subtypes of Gastroesophageal Reflux Disease.

Authors:  Jung-Hwan Oh; Tae-Suk Kim; Myung-Gyu Choi; Hyeug Lee; Eun-Jung Jeon; Sang-Wook Choi; Chul Lee; In-Sik Chung
Journal:  Gut Liver       Date:  2009-12-31       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.